Heart Rate Control in sepsis and septic shock

Similar documents
Dr Noryani Mohd Samat

Department of Intensive Care Medicine UNDERSTANDING CIRCULATORY FAILURE IN SEPSIS

TEACH Lesson Plan Manual for Herlihy s The Human Body in Health and Illness 5 th edition

Ventriculo-arterial coupling and diastolic elastance. MasterclassIC Schiermonnikoog 2015

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?

VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS

How to resuscitate the patient in early sepsis? A physiological approach. J.G. van der Hoeven, Nijmegen

Cardiovascular Management of Septic Shock

Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

Electrical Conduction

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Beta Blockade: Protection or Panacea

Impedance Cardiography (ICG) Method, Technology and Validity

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

The presentation based on Propofol infusion syndrome Ne-Hooi Will Loh, MBBS EDIC FRCA FFICM Priya Nair, MBBS FRCA FFICM Contin Educ Anaesth Crit Care

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Clinical Problem. Management. Discussion

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

Pharmacology of inotropes and vasopressors

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB

Disclaimer. Improving MET-based patient care using treatment algorithms. Michael R. Pinsky, MD, Dr hc. Different Environments Demand Different Rules

Atrial fibrillation in the ICU

Admission of patient CVICU and hemodynamic monitoring

Dilemmas in Septic Shock

When Fluids are Not Enough: Inopressor Therapy

UTILITY of ScvO 2 and LACTATE

John Park, MD Assistant Professor of Medicine

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Arrhythmias. Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium.

Cardiovascular health & Health Promotion HH2602 & HH5607

Impedance Cardiography (ICG) Application of ICG in Intensive Care and Emergency

Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya

towards early goal directed therapy

Goal-directed resuscitation in sepsis; a case-based approach

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction the Randomized SHOCK-COOL Trial

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007

Sepsis Combine experience and Evidence. Eran Segal, MD Director General ICU, Sheba Medical Center, Israel

Beta Blockers for ENT Surgery

The circulatory system

Intravenous Inotropic Support an Overview

Early Goal-Directed Therapy

Written 01/09/17 Rewritten 3/29/17 for Interior Regional EMS Symposium

TOPIC : Cardiogenic Shock

Introduction to Physiology (Course # 72336) 1. Adi Mizrahi Textbook Chapter 12

Shock and hemodynamic monitorization. Nilüfer Yalındağ Öztürk Marmara University Pendik Research and Training Hospital

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล

CKD Satellite Symposium

Meet the experts: Cardiogenic Shock

Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,

Vasoactive Drugs Do I have to choose? Dr. Vandewiele Bert 20 February 2012

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14

Cardiology. Objectives. Chapter

ANTI - ARRHYTHMIC DRUGS

Timing of Vasopressors in Septic Shock: How Soon is Too Soon?

Dysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias

Cardiac Output. Graphics are used with permission of: adam.com ( Benjamin Cummings Publishing Co (

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Titrating Critical Care Medications

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

9/13/2015. Laboratory. HPI and PE

McHenry Western Lake County EMS System CE for Paramedics, EMT-B and PHRN s Sepsis Patients. November/December 2017

The most common. hospitalized patients. hypotension due to. filling time Rate control in ICU patients may be difficult as many drugs cause hypotension

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart

Should we use steroids in sepsis? J.G. van der Hoeven

The Hemodynamic Puzzle

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

RV dysfunction and failure PATHOPHYSIOLOGY. Adam Torbicki MD, Dept Chest Medicine Institute of Tuberculosis and Lung Diseases Warszawa, Poland

PCV and PAOP Old habits die hard!

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

BETA BLOCKADE: IT S NOT JUST FOR CARDIOLOGY PATIENTS

Year in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

Sepsis is a complicated infectious process that propagates. Use of Vasopressors in Septic Shock. Clinical review

Topics to be Covered. Cardiac Measurements. Distribution of Blood Volume. Distribution of Pulmonary Ventilation & Blood Flow

Useful diagnostic measures: chest x ray to check pulmonary edema, ECG and ECHO to detect cardiac abnormalities (1).

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

WE NEED TO REDISCOVER PHYSIOLOGY!

Cardiovascular Physiology and Pharmacology

Impedance Cardiography (ICG) Application of ICG for Hypertension Management

Subclinical Problems in the ICU:

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

New Therapies for Sepsis

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

New Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD

Combination Therapy with Milrinone and Esmolol for Heart Protection in Patients with Severe Sepsis: A Prospective, Randomized Trial

Vasopressors in septic shock

DO 2 > VO 2. The amount of oxygen delivered is a product of cardiac output (L/min) and the amount of oxygen in the arterial blood (ml/dl).

Transcription:

Heart Rate Control in sepsis and septic shock Antonia Koutsoukou Associate Professor of Intensive Care Medicine University of Athens/ Sotiria General Chest Diseases Hospital

Introduction Sepsis, is a clinical syndrome that arises from an inappropriate and excessive inflammatory response against infection It is the leading cause of death among critically ill patients, predominantly as a consequence of multiple organ failure Hotchkiss and Karl. N Engl J Med 2003;348:138 Annane et al. Lancet 2005;365:63

Current understanding of sepsis-induced cardiovascular alterations heart under filling cardiac output O2 supply demand imbalance At this point, it seems odd that a β-blocking agent might have neutral or positive clinical impact So, why make a case in favor of β blockers? Hotchkiss and Karl. N Engl J Med 2003;348:138

Previous β-blocker use protects against sepsis-related mortality β-blocker use non β-blocker use Patients who receive chronic β-blocker prescription may have a survival advantage if they subsequently develop sepsis and are admitted to ICU Macchia et al. Crit Care Med 2012;40:2768

β blockers are safe in human sepsis Morelli et al. JAMA 2013;310:1683

β blockers are safe in human sepsis The authors concluded that administration of esmolol in septic shock patients was associated with a reduction in heart rate without adverse effects, while they noted a statistically significant difference in the secondary outcome of survival Heart Rate MAP Survival SVI CI MAP: Mean Arterial Pressure; SVI: Stroke Volume Index; CI: Cardiac Index Morelli et al. JAMA 2013;310:1683

Why this might have happened?

Severe Sepsis is characterized by excessive adrenergic stimulation Annane et al. Am J Resp Crit Care Med 1999;160:458

Adrenergic effects on heart Sympathetic effects on the heart are positive Inotropic ( contractility)* Chronotropic ( Heart Rate)* Dromotropic ( atrio-ventricular conduction) Lusitropic ( relaxation) * to meet increased requirements Annane et al. Am J Resp Crit Care Med 1999;160:458

Consequences of β1 adrenergic stimulation Activation of β1 adrenergic receptors contractility myocardial O2 demand tachycardia restricted diastolic filling and risk of decreased stroke volume O 2 requirements

Adrenergic storm! Exogenous catecholamine therapy Catecholamine toxicity Elevated heart rate after fluid resuscitation (and control of anemia, pain and agitation) may indicate an inappropriate degree of sympathetic activation and/or represent an adverse effect of catecholamine therapy

Cardiomyocyte-level adaptation during persistent adrenergic stimulation Down-regulation of β adrenergic receptors Internalization Desensitization Decreased Density Suzuki et al. Crit Care Med 2005;33:2294

Keep the sick from harm Hippocrates To prevent further damage, the cells have to reduce their energy requirements Iatrogenically, mimicking this with the use of β-blockers may protect the heart from sympathetic overstimulation Using β-blockers during severe sepsis might attenuate excessive tachycardia

What will be the effect on Cardiac Output? What will be the effect on Cardiac Efficiency? What will be the effect on Ventricular-Arterial Coupling? What will be the effect on microcirculation?

Our fears regarding β blockade effect on Cardiac Output Cardiac Output = Stroke Volume x Heart Rate Giving a combined negative inotropic and chronotropic agent might worsen cardiac output in septic shock

Our fears are partially true Heart Rate SV or SV Cardiac Output SV SV Cardiac Output Cardiac Output

Let s go back to physiology Kunada et al. Jpn J Physiol 1967;17:538

Lowering the heart rate Effect on Cardiac Output If the increase of heart rate is obtained by sympathetic stimulation, the increase of CO with increasing heart rate is greater than with pacing, because sympathetic stimulation has inotropic and lusitropic effects, that is it increases the contractility and increases the speed of relaxation of the myocardium during diastole.

Insignificant effect of heart rate reduction on Cardiac Output at the population level Morelli et al. JAMA 2013;310:1683

Lowering the heart rate Effect on Cardiac efficiency Heart Rate can limit the increased myocardial O 2 demand and its inherent risks The efficiency is the ratio between the external work and the energy which has been consumed to do that external work. Kunada et al. Jpn J Physiol 1967;17:538

β blockers in experimental sepsis Infusion of the β adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats β blocker treated animals developed higher Stroke Volume and Cardiac Output Suzuki et al. Crit Care Med 2005;33:2294

Ventricular-arterial (un)coupling What would be the effect of β-blockers on Ventricular-arterial uncoupling? Ea: Arterial Elastance; Ees: Endsystolic Elastance Suga et al. Am J Physiol 1983;244:H206 Guarracino et al. Crit Care 2014;18:R80

What about the microcirculation? Prospective observational study with specific focus on macrocirculation (Swan-Ganz) and microcirculation (Sidestream dark-field imaging) 25 septic patients who received a titrated esmolol infusion to a Heart Rate< 95 bpm Morelli et al. Crit Care Med 2013;41:2162

What about the microcirculation? Jacquet-Lagrèze et al. Crit Care 2015;19:241

Conclusions There is some evidence that β blocker use is safe in clinical sepsis and weak evidence of efficacy This challenges our current understanding of cardiovascular alterations leading to multi-organ failure This action might be mediated by alterations In cardiac output In cardiac efficiency In ventriculo-arterial uncoupling In the microcirculation More data are needed